Hot Products
| Catalog No. | Information |
| CFN90855 | Quercetagetin-7-O-glucoside Quercetagetin-7-O-glucoside, a potent inhibitor of beta-glucuronidase and lysozyme release, shows anti-inflammatory activity, can significantly inhibit arachidonic acid release from membranes. |
| CFN99272 | Quercetin Quercetin is one of the most prominent dietary antioxidants, it is claimed to exert beneficial health effects, this includes protection against various diseases such as osteoporosis, certain forms of cancer, pulmonary and cardiovascular diseases but also against aging. It is a stimulator of recombinant SIRT1 and also a PI3K inhibitor with IC50 of 2.4±0.6 μM, 3.0±0.0 μM and 5.4±0.3 μM for PI3K γ, PI3K δ and PI3K β, respectively. It also attenuated the function VEGFR, androgen receptor and the expressions of NF-κB, IL Receptor, FAK, ERK,Nrf2. |
| CFN89506 | Quercetin 3,3'-dimethyl ether Quercetin 3,3'-dimethyl ether may have moderate estrogenic activity. |
| CFN70333 | Quercetin 3,4'-diglucoside Quercetin 3,4'-diglucoside possesses antioxidant activities. |
| CFN98429 | Quercetin 3,4'-dimethyl ether Quercetin 3,4’-dimethyl ether shows anti-lipid peroxidation activity (IC 50 values of 0.3 uM), it also shows anti-inflammatory activity. Quercetin 3,4’-dimethyl ether could be useful in the development of novel anticancer agents, it has high cytotoxic against leukemia cells, it induces cell death is mediated by an intrinsic dependent apoptotic event involving mitochondria and MAPKs, and through a mechanism independent of the generation of reactive oxygen species. |
| CFN70262 | Quercetin 3,5,7,3,4-pentamethyl ether Quercetin 3,5,7,3′,4′-pentamethylether exhibits significant vasorelaxing properties. |
| CFN95486 | Quercetin 3,5-O-diglucoside |
| CFN95408 | Quercetin 3,7-diglucoside Quercetin 3,7-diglucoside exhibits antioxidant activity. |
| CFN95649 | Quercetin 3-glucosyl-(1->2)-galactoside |
| CFN91065 | Quercetin 3-O-(6''-galloyl)-beta-D-galactopyranoside Quercetin 3-O-(6''-galloyl)-beta-D-galactopyranoside can effectively induce apoptosis via p53, MAPKs and the mitochondrial apoptotic pathways. |
